CVS
CVS Health CorporationNYSEHealthcare$73.49+1.38%OpenMarket Cap: $93.49B
As of 2026-04-06
Valuation
P/E (TTM)
52.88
PEG
—
P/B
1.24
P/S
0.23
EV/EBITDA
18.11
DCF Value
$497.84
FCF Yield
8.4%
Div Yield
3.6%
Margins & Returns
Gross Margin
13.8%
Operating Margin
1.2%
Net Margin
0.4%
ROE
2.3%
ROA
1.2%
ROIC
2.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $105.69B | 12.8% | $2.11B | $2.94B | $2.30 | $0.67 |
| FY 2025 | $402.07B | 13.8% | $10.38B | $1.77B | $1.39 | $2.66 |
| Q3 2025 | $102.87B | 13.4% | $-3.21B | $-3.98B | $-3.13 | $0.67 |
| Q2 2025 | $98.92B | 13.7% | $2.38B | $1.02B | $0.80 | $0.67 |
| Q1 2025 | $94.59B | 15.2% | $3.37B | $1.78B | $1.41 | $0.67 |
| Q4 2024 | $97.71B | 13.2% | $2.37B | $1.64B | $1.30 | $0.67 |
| FY 2024 | $372.81B | 13.8% | $8.52B | $4.61B | $3.66 | $2.66 |
| Q3 2024 | $95.43B | 13.2% | $832.0M | $87.0M | $0.07 | $0.67 |
| Q2 2024 | $91.23B | 14.7% | $3.04B | $1.77B | $1.41 | $0.67 |
| Q1 2024 | $88.44B | 14.2% | $2.27B | $1.11B | $0.88 | $0.67 |
| Q4 2023 | $93.81B | 14.8% | $3.37B | $2.05B | $1.59 | $0.61 |
| FY 2023 | $357.78B | 15.2% | $13.74B | $8.34B | $6.47 | $2.42 |